Safety and Efficacy of ABT-510 in Subjects With Advanced Renal Cell Carcinoma

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

The primary objective of this study is to assess the safety and efficacy of ABT-510 in subjects with advanced renal cell carcinoma.

Phase 2

Abbott